← Open Payments lookup

ANDREA BOLEY: Open Payments

NPI 1083070346 · NEW HAVEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$278 in 16 payments from 11 companies in 2025. Trend: 2023 $276 · 2024 $396 · 2025 $278

Food & beverage: $278
CompanyPaymentsAmount
Astellas Pharma US Inc2$51
ABBVIE INC.3$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Lilly USA, LLC2$31
Sumitomo Pharma America, Inc.1$18
Corcept Therapeutics1$18
Vanda Pharmaceuticals Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
PFIZER INC.1$17
AstraZeneca Pharmaceuticals LP1$15

Products named: Veozah, VRAYLAR, CAPLYTA, MOUNJARO, GEMTESA, Korlym, UBRELVY, HETLIOZ.

Industry payments across IN — which companies pay providers there.